Full-Time

Growth Marketing & Acquisition Manager

Worry-Free Parenting

Philips

Philips

Healthcare technology for diagnosis, care, wellness

No salary listed

Farnborough, UK

Hybrid

At least three days in the office per week.

Category
Growth & Marketing (1)
Required Skills
Git
CRM
SEO
Data Analysis
Requirements
  • At least 5 years of experience in user acquisition for consumer mobile apps, including meaningful ownership of strategy across multiple channels and markets.
  • A track record of improving cost of acquisition through creative testing and a current understanding of modern paid platforms.
  • Strong command of mobile measurement, including attribution, mobile measurement partners, event and value tracking, and incrementality testing.
  • Experience selecting, onboarding, and directing agencies, freelancers, and specialists to deliver outcomes.
  • Hands-on experience with Meta Ads, Google UAC, Apple Search Ads, and TikTok, alongside familiarity with mobile attribution platforms such as Branch or similar mobile measurement partners.
  • Working knowledge of search engine optimisation and app store optimisation, plus curiosity about emerging acquisition channels such as generative engine optimisation, creator-led growth, and partnership-led growth.
  • Ability to translate brand strategy into channel execution and understand how creative, tone, and messaging consistency affect performance across Meta, TikTok, and search.
  • Ability to interpret data, challenge vanity metrics such as raw installs, and turn findings into prioritised actions and trade-offs.
  • Ability to execute independently when speed requires it, including turning around campaigns, shipping landing page tests, fixing tracking issues, or launching work directly.
  • Ability to influence product, engineering, analytics, and commercial stakeholders through strong communication and collaboration.
Responsibilities
  • Set and own the acquisition strategy across paid social, paid search, Apple Search Ads, app store optimisation, search engine optimisation, generative engine optimisation, and creator-led growth.
  • Own cost of acquisition and active user growth as headline metrics and make evidence-based decisions about spending and effort.
  • Continuously rebalance the channel mix, test new or under-exploited channels, scale effective approaches, and retire ineffective ones.
  • Build a high-output creative engine through user-generated-content specialists, creators, freelancers, and agency partners.
  • Write creative briefs grounded in audience insight, run structured testing frameworks, and feed winning signals back into platforms and the wider funnel.
  • Source, onboard, brief, and manage specialist partners including mobile user-acquisition agencies, creative producers, and channel specialists.
  • Hold partners accountable to clear outcomes and benchmarks, challenge their work, and step in when needed.
  • Own the measurement stack covering attribution, event tracking, and value-based signals, and run regular incrementality testing.
  • Automate reporting and account checks and simplify campaign structures to reduce manual budget management.
  • Partner with content, commercial, and partnership teams to unlock acquisition through healthcare, retail, and creator relationships.
  • Work with lifecycle and customer relationship management functions to connect acquisition with onboarding, activation, and retention.
  • Collaborate with product and engineering to improve store conversion, onboarding, and in-product moments that build long-term value.
Desired Qualifications
  • Genuine curiosity about emerging channels such as generative engine optimisation, creator-led growth, and partnership-led growth.

Philips develops health technology across professional medical devices, connected care, and consumer health products. Its offerings include diagnostic imaging and image-guided therapy, patient monitoring and clinical informatics, and everyday wellness products like oral and personal care. The company increasingly delivers integrated solutions through a Healthcare-as-a-Service subscription model and long-term partnerships with hospitals and health systems. Its aim is to improve people’s health and well-being by making advanced health technology easier to access and integrate into care.

Company Size

N/A

Company Stage

IPO

Headquarters

Andover, Minnesota

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • May 18, 2026 Stockholm selected Philips for hospital-at-home coverage across up to 15,000 patients annually.
  • Q1 2026 sales grew 4%, and Philips reiterated 2026 guidance on May 13, 2026.
  • 2025 free cash flow reached EUR 512 million, supporting investment and shareholder returns.

What critics are saying

  • August 2026 MDL still holds 624 Philips CPAP cases, extending legal drag.
  • January 19, 2026 settlement covers economics only; DOJ consent-decree talks still threaten Respironics.
  • A Respironics compliance failure can block U.S. sleep-device sales and tarnish Philips brand.

What makes Philips unique

  • June 4, 2026 WellSpan alliance makes Philips preferred vendor across CT, MR, X-ray, ultrasound, image-guided therapy.
  • August 6, 2026 ecosystem partnerships connect Philips monitoring from hospital beds to homes.
  • Philips combines diagnosis, connected care, and personal health across 64,317 employees at Q1 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Health Savings Account/Flexible Spending Account

Company News

PR Newswire
May 28th, 2026
Remote patient monitoring market to reach $117.9B by 2033 amid digital healthcare transformation

The global remote patient monitoring market is expected to grow from $67.3 billion in 2026 to $117.9 billion by 2033, registering a CAGR of 8.3%. Growth is driven by rising chronic disease prevalence, expanding telehealth services and increasing demand for home-based healthcare solutions. Devices and hardware account for nearly 38% of market share, led by connected blood pressure monitors, glucometers and wearable health trackers. North America holds approximately 41% of the global market, supported by strong digital healthcare infrastructure and favourable reimbursement policies. Asia Pacific is emerging as the fastest-growing region, driven by healthcare digitisation, telemedicine expansion and rising smartphone penetration. Leading players include Philips Healthcare, Medtronic, GE HealthCare and Abbott Laboratories, focusing on AI integration and cloud connectivity to enhance remote care delivery.

HIT Consultant
Apr 12th, 2024
Philips Respironics Reaches Final Agreement With Us Regulators On Sleep Apnea Device Recall

<img src="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp" alt="Philips Respironics Reaches Final Agreement with US Regulators on Sleep Apnea Device Recall. " class="wp-image-78777" srcset="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp 700w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-300x161.webp 300w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-290x155.webp 290w" sizes="(max-width: 700px) 100vw, 700px">What You Should Know: – Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a 2021 inspection of a Philips facility in Pennsylvania.– The agreement focuses on Philips Respironics’ operations in the US, particularly regarding the recall of certain sleep and respiratory care devices.– The company’s focus will now be on completing remediation efforts, ensuring patient safety, and regaining regulatory approval to resume sales of new devices in the US.Focus on Remediation and ComplianceThe consent decree outlines a roadmap for Philips Respironics to:Prioritize Recall Remediation: Philips will continue efforts to remediate millions of sleep apnea and respiratory care devices recalled in June 2021 due to potential health risks associated with degraded sound abatement foam.Independent Oversight: Independent experts will be brought in to review recall remediation efforts and ensure Philips Respironics’ business operations comply with FDA regulations.Continued Patient Support: Philips Respironics can continue servicing existing devices in the hands of patients and healthcare providers. Additionally, they can sell accessories, consumables, and replacement parts for these devices.Sales Restrictions Remain in USThe FDA has not yet authorized Philips Respironics to resume sales of new CPAP, BiPAP, or other respiratory care devices in the US. This restriction will remain in place until Philips meets the requirements outlined in the consent decree.Global Sales Continue with RestrictionsPhilips Respironics can continue to sell new devices, accessories, consumables, and replacement parts outside the US,  subject to specific requirements.Safety of Devices with New Foam ConfirmedPhilips Respironics has conducted tests on devices using a new silicone sound abatement foam and found no safety issues. Patients can continue to use these devices following the instructions for use.Financial ImpactPhilips anticipates incurring costs associated with remediation activities and profit disgorgement related to US sales. These costs are estimated at 100 basis points in 2024.  The company’s previously announced 2023-2025 financial outlook remains unchanged,  already factoring in the consent decree. “Strengthening patient safety and quality remains Philips’ highest priority and the increased scrutiny will help us to improve even more

Goodrich Pharmacy
Jan 29th, 2024
Phillips Suspends U.S. Sales of CPAP, Ventilator Machines After Recall

Following a recall of millions of its breathing machines that began in mid-2021, Phillips Respironics announced Monday that it would halt sales of all such machines within the United States.

YourLawyer.com
Mar 23rd, 2023
Sleep Apnea Patients Suffer While Waiting To Receive Their Repaired Philips CPAP Machines

In June of 2021, Philips began a recall of over five million of its breathing devices due to toxic fume and substances emanating from the devices’ sound abatement foam.

Digital Journal
Jan 13th, 2023
Ultrasound Market Share | Market | Report | Analysis 2032 | Key Players: Fujifilm Holdings Corporation, Analogic Corporation, Siemens Healthcare among others

February 2019 – Koninklijke Philips launched the EPIQ Elite ultrasound system in the market.